Meanwhile, in cisplatin-resistant gastric cancer cells, the activity of another anti-apoptotic gene—AKT1, an element of the PI3K/Akt signaling pathway (involved in the regulation of cell proliferation, death, and survival)—increases in response to cisplatin treatment [68]. Here, AKT1 is linked to gastric cancer.